Roy Hartvig Larsen
Chief Executive Officer at Sciencons AS
Net worth: 199 920 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Tina Bjørnlund Bønsdorff | M | 53 |
Oncoinvent AS
 Oncoinvent AS Pharmaceuticals: MajorHealth Technology Oncoinvent AS develops antibody based therapeutic molecules for cancer treatment. It offers antigen-binding domains that develops coupling to nanoparticles and drug candidates. The firm provides antibodies (the OI-antibodies) with clinical relevant binding-specificity and also designs molecules and drug conjugates for treatment of specific cancer diseases. The company was founded by Tina Bjornlund Bonsdorff, ?yvind Sverre Bruland, Roy Hartvig Larsen, and Thora Johanna Jonasdottir in 2010 and is headquartered in Oslo, Norway. | 14 years |
| Thora Johanna Jonasdottir | M | 59 |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Oncoinvent AS develops antibody based therapeutic molecules for cancer treatment. It offers antigen-binding domains that develops coupling to nanoparticles and drug candidates. The firm provides antibodies (the OI-antibodies) with clinical relevant binding-specificity and also designs molecules and drug conjugates for treatment of specific cancer diseases. The company was founded by Tina Bjornlund Bonsdorff, ?yvind Sverre Bruland, Roy Hartvig Larsen, and Thora Johanna Jonasdottir in 2010 and is headquartered in Oslo, Norway. | 14 years |
| Adrian M. Senderowicz | M | 60 |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Oncoinvent AS develops antibody based therapeutic molecules for cancer treatment. It offers antigen-binding domains that develops coupling to nanoparticles and drug candidates. The firm provides antibodies (the OI-antibodies) with clinical relevant binding-specificity and also designs molecules and drug conjugates for treatment of specific cancer diseases. The company was founded by Tina Bjornlund Bonsdorff, ?yvind Sverre Bruland, Roy Hartvig Larsen, and Thora Johanna Jonasdottir in 2010 and is headquartered in Oslo, Norway. | 2 years |
| Anders Månsson | M | 57 |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Oncoinvent AS develops antibody based therapeutic molecules for cancer treatment. It offers antigen-binding domains that develops coupling to nanoparticles and drug candidates. The firm provides antibodies (the OI-antibodies) with clinical relevant binding-specificity and also designs molecules and drug conjugates for treatment of specific cancer diseases. The company was founded by Tina Bjornlund Bonsdorff, ?yvind Sverre Bruland, Roy Hartvig Larsen, and Thora Johanna Jonasdottir in 2010 and is headquartered in Oslo, Norway. | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Per Anders Göte Samuelsson | M | 63 | 8 years | |
| Tone Kvåle | F | 55 | 8 years | |
| Øyvind Sverre Bruland | M | 72 |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Oncoinvent AS develops antibody based therapeutic molecules for cancer treatment. It offers antigen-binding domains that develops coupling to nanoparticles and drug candidates. The firm provides antibodies (the OI-antibodies) with clinical relevant binding-specificity and also designs molecules and drug conjugates for treatment of specific cancer diseases. The company was founded by Tina Bjornlund Bonsdorff, ?yvind Sverre Bruland, Roy Hartvig Larsen, and Thora Johanna Jonasdottir in 2010 and is headquartered in Oslo, Norway. | - |
| Ludvik Sandnes | M | - | 6 years | |
| Anniken Hagen | F | 61 | - | |
| Bjørg Bolstad | F | - | 3 years | |
| Thomas Ramdahl | M | 68 | - | |
| Jónas Einarsson | M | 67 |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Oncoinvent AS develops antibody based therapeutic molecules for cancer treatment. It offers antigen-binding domains that develops coupling to nanoparticles and drug candidates. The firm provides antibodies (the OI-antibodies) with clinical relevant binding-specificity and also designs molecules and drug conjugates for treatment of specific cancer diseases. The company was founded by Tina Bjornlund Bonsdorff, ?yvind Sverre Bruland, Roy Hartvig Larsen, and Thora Johanna Jonasdottir in 2010 and is headquartered in Oslo, Norway. | - |
| Theresa Comiskey Olsen | F | 61 | - | |
| Marco Renoldi | M | 67 | 8 years | |
| Bente-Lill Romøren | F | 75 | - | |
| Jostein Dahle | M | 51 | - | |
| Jean Bizzari | M | 69 | - | |
| John Berriman | M | 76 | 4 years | |
| Gisela Schwab | M | 67 | 5 years | |
| Hilde Hermansen Steineger | M | 58 | 7 years | |
| Jan Alan Alfheim | M | - |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Oncoinvent AS develops antibody based therapeutic molecules for cancer treatment. It offers antigen-binding domains that develops coupling to nanoparticles and drug candidates. The firm provides antibodies (the OI-antibodies) with clinical relevant binding-specificity and also designs molecules and drug conjugates for treatment of specific cancer diseases. The company was founded by Tina Bjornlund Bonsdorff, ?yvind Sverre Bruland, Roy Hartvig Larsen, and Thora Johanna Jonasdottir in 2010 and is headquartered in Oslo, Norway. | 12 years |
| Stein Holst Annexstad | M | 80 | - | |
| Alexandra Morris | F | 62 | 2 years | |
| Olav Steinnes | M | 67 | - | |
| Kari Grønås Dyvik | F | 60 | - | |
| Renee Tannenbaum | M | 72 | - | |
| Ragnhild Marie Løberg | F | 71 | - | |
| Geir Christian Melen | M | 60 | 11 years | |
| Luigi Costa | M | 59 | 4 years | |
| Vidar Hansson | M | - | - | |
| Björn Ingemar Odlander | M | 66 | 1 years | |
| Cristina Oliva | M | - | 2 years | |
| Rita Dege | F | 57 | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Norway | 33 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Roy Hartvig Larsen
- Personal Network